ALC:NYSE
Alcon AG
$73.89
arrow_downward
-0.31%(-0.23) 1D
Nov 16, 1:36:22 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ALC...
Open
$74.35
High
$74.76
Low
$73.79
Mkt. cap
31.19B
Avg. vol.
2.14M
Volume
738.62K
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
Open
$74.35
High
$74.76
Low
$73.79
Mkt. cap
31.19B
Avg. vol.
2.14M
Volume
738.62K
52-wk high
$87.64
52-wk low
$61.84
Beta
0.87
Shares outstanding
483.40M
No. of employees
25K
News stories
From web sources and news partners
ChartMill
·
1 hour ago
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
marketscreener.com
·
1 hour ago
Nasdaq, S&P 500 fall over 1% in run-up to Nvidia results, Anthropic debut
Stocktwits
·
1 hour ago
Morgan Stanley’s Mike Wilson Is Bullish On S&P 500 With A 15% Upside View For 2027
Traders Union
·
3 hours ago
Peter Tuchman: S&P 500 loses over $800 billion in market cap
Profile
Alcon Inc. is a Swiss-American pharmaceutical and medical device company specializing in eye care products. Alcon is incorporated in the Canton of Fribourg, Switzerland, and its global headquarters are located in Geneva, but its main operational base is in Fort Worth, Texas, United States, where it employs about 4,500 people.
Alcon was a subsidiary of Novartis until April 2019, when it was spun out into a separate publicly traded company. Alcon itself has a number of subsidiaries, including Aerie Pharmaceuticals, focused on therapies for glaucoma and other diseases of the eye, and WaveLight, which develops and manufactures laser eye surgery technologies. Wikipedia
About Alcon AG
CEODavid J. Endicott
Employees25K
Founded1945
HeadquartersGeneva, Geneva, Switzerland
SectorHealth Care
IndustryMedical device
Websitealcon.com